Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Businesswire News Releases

May 30, 2024 07:30 ET
CinRx Pharma Announces Additional $73 Million Financing
CinRx Pharma, a hub-and-spoke biotech accelerating high-impact medicines, today announced the closing of a $73 million financing, bringing the total funds raised to $176 million. Participants in the round include prior investors comprised of industry insiders and high-net-worth individuals. To date, CinRx has launched five companies (“CinCos”) focused primarily on cardiovascular, metabolic and gastrointestinal conditions. In addition to its company creation function, CinRx has forged several CINergy partnerships with existing companies. CinRx plans to use the funds to advance development of it...
May 30, 2024 07:30 ET
Endace and Telchemy Integration Provides Optimized Unified Communications and Superior Network Performance Management and Monitoring
Telchemy and Endace today announced an integration partnership that optimizes customers’ Quality of Experience (QoE) and e...
May 30, 2024 07:30 ET
Former Merck Director and Vanderbilt Vice-Chancellor, Dr. Harry Jacobson, to Join Lobe Sciences Board of Directors
Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announced that Dr. Harry Jacobson has agreed to join its Board of Directors in the coming months....
May 30, 2024 07:30 ET
KUBRA Partners with Systems & Software to Transform Utility Customer Experience
KUBRA and Systems & Software (S&S) proudly announce a strategic partnership that combines their respective industry strengths to elevate the utility customer experience. By integrating KUBRA’s expertise in customer experience management solutions with the robust capabilities of S&S’s enQuesta Customer Information System (CIS), this partnership focuses on enhancing the efficiency and effectiveness of utility customer service operations. This collaboration between the two companies' technologies promises to deliver a seamless, user-centric experience, highlighting our commitment to excellence an...
May 30, 2024 07:30 ET
Monro, Inc. to Participate at the 2024 RBC Capital Markets Consumer Day
Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, today announced that Michael T. Broderick, President and Chief Executive Officer, Brian D’Ambrosia, Executive Vice President and Chief Financial Officer and Felix Veksler, Senior Director of Investor Relations, will participate in a Fireside Chat at the 2024 RBC Capital Markets Consumer Day on Thursday, June 6, 2024 at 10:40 AM ET. A live webcast of the RBC Capital Markets Consumer Day event will be available via the “Investors” section of the Company’s corporate website (
May 30, 2024 07:30 ET
Vecima Named Backup Bidder in Bankruptcy Auction for Casa Systems’ Cable Business
Vecima Networks, Inc. (TSX: VCM) (“Vecima”) today announced that its subsidiary, Vecima Technology Inc., was designated the back-up bidder at an auction to acquire the Cable Business assets (the “Cable Business Assets”) of Casa Systems, Inc., with Vecima’s top bid at USD$44.95 million. Approval of the sale to the winning bidder is subject to approval by the U.S. Bankruptcy Court for the District of Delaware at a hearing next week....
May 30, 2024 07:30 ET
Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced topline results from its recently completed Phase 2 multi-center, open label, study of XP-8121 for the treatment of adults with hypothyroidism. XP-8121 employs the Company’s XeriSol™ formulation technology to enable a novel once-weekly SC injection of levothyroxine. This novel formulation significantly increases the bioavailability of levothyroxine reducing overall dru...
May 30, 2024 07:05 ET
AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced new data to be presented at the 2024 American Transplant Congress (ATC) being held June 1-5 in Philadelphia....
May 30, 2024 07:05 ET
POSaBIT Announces Anticipated Late Filing of the First Quarter Interim Filings
POSaBIT Systems Corporation (CSE: PBIT, OTC: POSAF) (the "Company" or "POSaBIT"), announces today that the Company is anticipating a delay in filing its interim financial statements and accompanying management's discussion and analysis for the three months ended March 31, 2024 (the "Q1 Interim Filings"), by the filing deadline on May 30, 2024 (the "Filing Deadline"), as required by National Instrument 51-102 – Continuous Disclosure Obligations....
May 30, 2024 07:03 ET
Taiwan Embedded Finance Business Report 2024-2029: Open Banking Paves the Way for Collaborative Fintech Ecosystems, High Smartphone Penetration Fuels Mobile-First Finance - ResearchAndMarkets.com
The "Taiwan Embedded Finance Business and Investment Opportunities Databook - 75+ KPIs on Embedded Lending, Insurance, Payment, and Wealth Segments - Q1 2024 Update" report has been added ...
May 30, 2024 07:03 ET
The Daniels Corporation Unveils 2023 Impact Report, Highlighting Social Impact Initiatives and Progress on the Decarbonization Roadmap
The Daniels Corporation (“Daniels”), one of Canada's pre-eminent builders and developers, recognized for its commitment to city-building and social impact, proudly presents its 2023 impact report. This report is a testament to the company’s unwavering dedication to fostering inclusive and sustainable communities....
May 30, 2024 07:00 ET
Angeles Equity Partners Acquires O’Hara’s Son Roofing
An affiliate of Angeles Equity Partners, LLC (“Angeles”), a private investment firm that partners with niche manufacturing, critical industrial services, and specialty distribution businesses in an effort to realize their full potential, has acquired
May 30, 2024 07:00 ET
Chemtrade Logistics Income Fund Announces Normal Course Issuer Bid
Chemtrade Logistics Income Fund (TSX: CHE.UN) (“Chemtrade” or the “Fund”) today announced that the Toronto Stock Exchange ("TSX") has accepted its notice of intention to proceed with a normal course issuer bid ("NCIB")....
May 30, 2024 07:00 ET
EV Purchase Consideration Cools for Second Consecutive Year in Canada, J.D. Power Finds
Just 11% of new-vehicle shoppers in Canada say they are “very likely” to consider an electric vehicle (EV) for their next purchase, down 3 percentage points from 2023 and less than half of the 24% of U.S. shoppers who say they are “very likely” to consider an EV. That strong sense of resistance is the dominant theme of the J.D. Power 2024 Canada Electric Vehicle Consideration (EVC) Study,SM released today, which finds that perceptions of limited driving distance per charge, high purchase price and lack of charging station availability are the biggest factors limiting EV consideratio...
May 30, 2024 07:00 ET
G-III Apparel Group Announces Date for First Quarter 2025 Results
G-III Apparel Group, Ltd. (NASDAQ: GIII) a global fashion leader with expertise in design, sourcing, and manufacturing, today announced that it will release its first quarter 2025 earnings before the market opens on Thursday, June 6, 2024. Management will host a conference call to discuss results at 8:30 a.m. ET that same day, followed by a question and answer session for the investment community....
May 30, 2024 07:00 ET
Kohl's Reports First Quarter Fiscal 2024 Financial Results
Kohl’s Corporation (NYSE:KSS) today reported results for the first quarter ended May 4, 2024....
May 30, 2024 07:00 ET
Laser Photonics To Attend NCMS Technology Showcase at Marine Depot Maintenance Command in Georgia
Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading gl...
May 30, 2024 07:00 ET
Medable to Present at Jefferies Global Healthcare Conference
Medable Inc., the leading evidence-generation platform provider for modern clinical trials, today announced that Medable Co-founder and CEO Michelle Longmire will present at the Jefferies Global Healthcare Conference. The live presentation will take place on Thursday, June 6, 2024, at 3:30p.m. ET in New York City, New York....
May 30, 2024 07:00 ET
Montrose Environmental Group to Attend Upcoming Investor Conferences
Montrose Environmental Group, Inc. (the “Company,” “Montrose” or “MEG”) (NYSE: MEG) today announced that President and Chief Executive Officer, Vijay Manthripragada and Chief Financial Officer, Allan Dicks, will attend the following investor conferences:...
May 30, 2024 07:00 ET
Precision BioSciences to Participate in Upcoming June Investor Conferences
Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today announced that members of management will participate in the following upcoming investor conferences in June:...